XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 353,069 $ 164,894
Marketable securities 232,045 285,605
Trade accounts receivable, net of allowance for credit losses of $22,126 and $11,217 160,261 138,912
Other current assets 19,958 22,549
Total current assets 765,333 611,960
Marketable securities, long-term 493,182 485,047
Redeemable preferred stock investment 17,609 21,965
Fixed assets, net 68,622 62,287
Intangible assets, net 35,037 35,914
Goodwill 50,999 50,897
Other long-term assets 34,808 10,650
Total assets 1,465,590 1,278,720
Current liabilities    
Accounts payable 23,699 20,494
Accrued liabilities 11,847 17,689
Income tax payable 52,163 787
Contract liabilities 14,102 14,570
Customer deposit 17,729 19,806
Investment margin loan 14,999 15,137
Contingent consideration 10,000
Notes payable, current portion 6,086 6,147
Other current liabilities 1,089 680
Total current liabilities 141,714 105,310
Unrecognized tax benefits 1,210 725
Other long-term liabilities 9,706 6,805
Total liabilities 152,630 112,840
Commitments and contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.0001 par value per share, 50,000 shares authorized, 30,327 and 30,160 shares issued and outstanding 3 3
Preferred stock, $0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding
Additional paid-in capital 507,046 501,908
Accumulated other comprehensive loss (12,493) (759)
Retained earnings 811,576 657,597
Total Fulgent stockholders' equity 1,306,132 1,158,749
Noncontrolling interest 6,828 7,131
Total stockholders’ equity 1,312,960 1,165,880
Total liabilities and stockholders’ equity $ 1,465,590 $ 1,278,720